Delivery Order SPE2DB22D3501-SPE2DB25FXF75
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively competed delivery order valued at $8,327.64 on August 7, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which serves as a child contract to a larger vehicle, is scheduled for ultimate completion on August 8, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $134,839.30 on September 10, 2025, by the Defense Logistics Agency's Medical Supply Chain. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of September 11, 2025, and represents a child contract under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,045.35 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, represents a continuation of the company's extensive role as a critical federal medical supplier. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award on July 28, 2025, valued at $13,817.42 under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. This non-set-aside, competitively awarded delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 through December...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $3,594.26 from the Defense Logistics Agency's Medical Supply Chain on August 12, 2025. This competitively awarded, firm fixed-price delivery order carries an ultimate completion date of August 12, 2025 and involves pharmaceutical products and medical supplies to support federal healthcare operations. The award represents a child contract action under a larger contract vehicle,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,646.14 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 4, 2025. This non-competitive, firm fixed price delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at approximately $1 billion...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order valued at $4,718.87 from the Defense Logistics Agency's Medical Supply Chain on August 20, 2025. This firm fixed-price delivery order, which represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), is scheduled for completion by August 21, 2025. The award was made through open...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $1,247.80 by the Defense Logistics Agency's Medical Supply Chain on September 8, 2025. This competitively awarded, firm fixed-price delivery order is unset-aside and has an ultimate completion date of September 9, 2025. The contract represents a child order issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,336.48 on July 31, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 1, 2025. The contract serves as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $452,841.60 on September 8, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This competitive award, which is not set-aside, is structured as a firm fixed price delivery order with an ultimate completion date of September 9, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXF75Delivery Order
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 9, 2025, for Persaris ER 90 mg syringe kits valued at $8,527.44. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor and critical supplier to federal medical procurement programs. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The DLA awarded this contract through open competition, reflecting the company's demonstrated capability to meet federal healthcare supply requirements and serve customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.5k | 9/9/25 |